Pregnancy after breast cancer in BRCA1/2 mutation carriers
ConclusionAccording to the existing literature evidence pregnancy after therapy for breast cancer inBRCA carriers is safe for the mother and offspring, but patients ’ needs, oncofertility counseling and fertility-sparing strategy should be carefully planned before starting the cytotoxic treatment.
Source: Hereditary Cancer in Clinical Practice - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Pregnancy | Pregnancy and Breast Cancer | Reproduction Medicine | Women